Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 71, n° 4
pages 832-833 (octobre 2014)
Doi : 10.1016/j.jaad.2014.05.073
Notes & Comments

Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea

Leah A. Swanson, BS a, Erin M. Warshaw, MD, MS a, b,
a University of Minnesota School of Medicine, Minneapolis, Minnesota 
b Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota 

Correspondence to: Erin M. Warshaw, MD, MS, Dept 111K VAMC, 1 Veterans Drive, Minneapolis, MN 55417

 Funding sources: None.
 Conflicts of interest: None declared.
 This material is the result of work supported with resources and the use of facilities at the Minneapolis VA Medical Center. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.

Top of the page

© 2014  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline